At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleRevenue is $29.31M, lower than 95% of all stocks globally
- PositionReturn on equity is 27.4%, higher than 95% of its Medical Devices peers (median 2.5%)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.39BILS465.10M · vs all stocks (USD)
Trailing P/E
62.00xvs Medical Devices peers
Revenue (TTM)
87.64MUSD29.31M · vs all stocks (USD)
Profit Margin
8.48%vs Medical Devices peers
Beta
0.6520xvs all stocks
52-Week Change
44.44%vs all stocks
Market Capitalization
1.39BILS465.10M · vs all stocks (USD)
Enterprise Value
1.39BILS464.98M · vs all stocks (USD)
Trailing P/E
62.00xvs Medical Devices peers
Price to Sales (TTM)
12.94xvs Medical Devices peers
Price to Book (MRQ)
35.43xvs Medical Devices peers
Enterprise to Revenue
12.56xvs Medical Devices peers
Enterprise to EBITDA
114.61xvs Medical Devices peers
Gross Margin
74.98%vs Medical Devices peers
Profit Margin
8.48%vs Medical Devices peers
Operating Margin
9.53%vs Medical Devices peers
Return on Assets (TTM)
11.83%vs Medical Devices peers
Return on Equity (TTM)
27.43%vs Medical Devices peers
Revenue (TTM)
87.64MUSD29.31M · vs all stocks (USD)
Revenue per Share (TTM)
2.91USDUpdated Aug 29, 2026Quarterly Revenue Growth
42.70%vs Medical Devices peers
Gross Profit (TTM)
65.96MUSD22.06M · vs all stocks (USD)
EBITDA (TTM)
7.61MUSD2.55M · vs all stocks (USD)
Net Income (TTM)
5.49MUSD1.83M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
65.50%vs Medical Devices peers
Operating Cash Flow (TTM)
13.29MUSD4.45M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
5.49MUSD1.83M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00ILSUpdated Aug 29, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
87.64MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
21.68MUSDFY2025 · Dec 31, 2025Gross Profit
65.96MUSDFY2025 · Dec 31, 2025Operating Income
6.87MUSDvs all stocks (USD)
Pre-tax Income
5.74MUSDFY2025 · Dec 31, 2025Income Tax Expense
249.00KUSDFY2025 · Dec 31, 2025Net Income
5.49MUSDFY2025 · Dec 31, 2025EBIT
5.80MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
7.61MUSDFY2025 · Dec 31, 2025Research & Development
12.80MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
21.59MUSDFY2025 · Dec 31, 2025Other Operating Expenses
270.00KUSDFY2025 · Dec 31, 2025Non-operating Interest Income
674.00KUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
69.00KUSDFY2025 · Dec 31, 2025EPS (Basic)
0.1500USDFY2025 · Dec 31, 2025EPS (Diluted)
0.1400USDFY2025 · Dec 31, 2025Basic Shares Outstanding
35.40MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
35.40MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
5.49MUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00USDFY2025 · Dec 31, 2025Operating Cash Flow
7.52MUSDFY2025 · Dec 31, 2025Free Cash Flow
6.99MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
34.75MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
5.49MUSDFY2025 · Dec 31, 2025Stock-based Compensation
2.32MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-432.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
488.00KUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-342.00KUSDFY2025 · Dec 31, 2025Capital Expenditures
-534.00KUSDFY2025 · Dec 31, 2025Purchase of Investments
-525.00KUSDFY2025 · Dec 31, 2025Sale of Investments
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.06MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
378.00KUSDFY2025 · Dec 31, 2025Shares Outstanding
36.10MSharesUpdated Aug 29, 2026Float Shares
17.20MSharesUpdated Aug 29, 2026% Held by Insiders
40.10%vs all stocks
% Held by Institutions
29.24%vs all stocks
Total Cash per Share (MRQ)
1.06USDUpdated Aug 29, 2026Total Debt (MRQ)
1.43MUSD476.85K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0375xvs Medical Devices peers
Current Ratio (MRQ)
2.46xvs Medical Devices peers
Book Value per Share (MRQ)
1.05USDUpdated Aug 29, 2026Total Assets
55.77MUSDvs all stocks (USD)
Total Current Assets
51.26MUSDFY2025 · Dec 31, 2025Total Liabilities
23.06MUSDFY2025 · Dec 31, 2025Total Non-current Assets
4.51MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
728.00KUSDFY2025 · Dec 31, 2025Total Current Liabilities
22.33MUSDFY2025 · Dec 31, 2025Cash
34.75MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
34.75MUSDFY2025 · Dec 31, 2025Other Short-term Investments
169.00KUSDFY2025 · Dec 31, 2025Accounts Receivable
7.62MUSDFY2025 · Dec 31, 2025Inventory
5.00MUSDFY2025 · Dec 31, 2025Accounts Payable
8.09MUSDFY2025 · Dec 31, 2025Short-term Debt
665.00KUSDFY2025 · Dec 31, 2025Long-term Debt
459.00KUSDFY2025 · Dec 31, 2025Common Stock (Book)
0.00USDFY2025 · Dec 31, 2025Retained Earnings
-52.54MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
32.71MUSDvs all stocks (USD)
52-Week Low
2.42KILAUpdated Aug 29, 202652-Week High
4.87KILAUpdated Aug 29, 202652-Week Change
44.44%vs all stocks
Beta
0.6520xvs all stocks
50-Day MA
3.99KILAUpdated Aug 29, 2026200-Day MA
3.74KILAUpdated Aug 29, 2026Avg 10-Day Volume
65.08KSharesUpdated Aug 29, 2026Avg 30-Day Volume
72.54KSharesUpdated Aug 29, 2026Diluted EPS (TTM)
0.6000USDUpdated Aug 29, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is 27.4%, higher than 95% of its Medical Devices peers (median 2.5%)Significant
Return on equity: 0.27Industry median: 0.03Industry P95: 0.17Peers compared: 102
Return on assets is 11.8%, higher than 95% of its Medical Devices peers (median 1.7%)Significant
Return on assets: 0.12Industry median: 0.02Industry P95: 0.12Peers compared: 102
Price-to-book is 35.43×, higher than 95% of its Medical Devices peers (median 2.49×)Significant
Price-to-book: 35.43Industry median: 2.49Industry P95: 14.49Peers compared: 102
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.56
Altman Z-Score 13.17: safe zoneNotable
Altman Z-Score: 13.17
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Revenue is $29.31M, lower than 95% of all stocks globallySignificant
Revenue (USD): 29,305,812.8Global P5: 32,166,921.735
Coordination data is not yet available for this stock.